Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease. (Q53226489)

12 May 2018

title

Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease. (English)

1 reference

12 May 2018

author name string

Scacchi R

1

1 reference

12 May 2018

Gambina G

2

1 reference

12 May 2018

Ruggeri M

3

1 reference

12 May 2018

Martini MC

4

1 reference

12 May 2018

Ferrari G

5

1 reference

12 May 2018

Silvestri M

6

1 reference

12 May 2018

Schiavon R

7

1 reference

12 May 2018

Corbo RM

8

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

12 May 2018

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

12 May 2018

volume

259

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

33-36

1 reference

12 May 2018

An AvaII polymorphism in the human apolipoprotein C-II gene

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900889-1

7 January 2021

Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900889-1

7 January 2021

APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900889-1

7 January 2021

Genetic association study between senile dementia of Alzheimer's type and APOE/C1/C2 gene cluster

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900889-1

7 January 2021

Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900889-1

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900889-1

7 January 2021

Apolipoprotein E polymorphism and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900889-1

7 January 2021

Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900889-1

7 January 2021

Genetic association and linkage analysis of the apolipoprotein CII locus and familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900889-1

7 January 2021

Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900889-1

7 January 2021

Rare apolipoprotein E variant cosegregating with a unique APOE-C1-C2 haplotype in a normolipidemic family

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900889-1

7 January 2021

ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900889-1

7 January 2021

Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900889-1

7 January 2021

Apolipoprotein E genotyping by one-stage PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900889-1

7 January 2021

Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900889-1

7 January 2021

10.1016/S0304-3940(98)00889-1

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

10027549

1 reference

12 May 2018